AI-Assisted Treatment for Residual Speech Sound Disorders

Syracuse University

Status: Enrolling

Conditions: Speech Sound Disorder

Treatments: Behavioral: Artificial Intelligence-led Speech Motor Chaining (CHAINING-AI); Behavioral: Speech-Language Pathologist-led Speech Motor Chaining

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05988515

1R01DC020959-01 (U.S. NIH Grant/Contract)

22-426b

Details and patient eligibility

About

The goal of this randomized-controlled trial is to determine how artificial intelligence-assisted home practice may enhance speech learning of the "r" sound in school-age children with residual speech sound disorders. All child participants will receive 1 speech lesson per week, via telepractice, for 5 weeks with a human speech-language clinician. Some participants will receive 3 speech sessions per week with an Artificial Intelligence (AI)-clinician during the same 5 weeks as the human clinician sessions (CONCURRENT treatment order group), whereas others will receive 3 speech sessions per week with an AI-clinician after the human clinician sessions end (SEQUENTIAL treatment order group.

Full description

Artificial Intelligence-assisted treatment that detects mispronunciations within an evidence-based motor learning framework could increase access to sufficiently intense, efficacious treatment despite provider shortages. A successful Artificial intelligencesystem that can predict the clinical gold standard of trained listeners' perceptions could not only improve access to clinical care but also mitigate known confounds to accurate clinical feedback, including clinical experience and drift due to increasing familiarity between the speaker and listener. The Artificial intelligence tool used in this study includes a speech classifier trained to predict clinician judgment of American English "r" that is integrated into an existing evidence-based treatment software called Speech Motor Chaining.

Enrollment: 26 estimated patients

Sex: All

Ages: 9 to 17 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Must speak a rhotic dialect of American English as a dominant language.
• Must have begun learning English by at least the age of 3 years.
• Must be between 9;0 to 17;11 years of age.
• Must have reported difficulty with /ɹ/ production.
• Must have reported hearing within normal limits.
• Must receive a Scaled Score of 5 or above on both the Listening Comprehension and Story Retelling subtests from the Test of Integrated Language & Literacy Skills (TILLS).
• Must receive a percentile score of 8 or below on the Goldman-Fristoe Test of Articulation-3 (GFTA-3) Sounds in Words subtest.
• Must have 1 scorable response with 5+ consecutive correct /pataka/ with > 3.4 syllables per second in the MRR-Tri task of the Maximum Performance Tasks OR must demonstrate no childhood apraxia of speech (CAS-only) features in BOTH articulatory and rate/prosody domains of the ProCAD.
• Must score <40% accurate based on word-level items from our /ɹ/ probe list.
• Must score >=15% accuracy on /ɹ/ on 45 syllables following Dynamic Assessment.
• Must express interest in changing their /ɹ/ production.
• Must have oral structure and function that are appropriate for /ɹ/ production.
• Must have access to broadband internet with videoconferencing capabilities

Exclusion criteria

• Must have no known history of autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke.
• Must not have diagnosis of attention deficit disorder, attention deficit hyperactivity disorder, Tourette's, or Obsessive-compulsive disorder.
• Must have no orthodontic appliances that block the roof of the mouth (e.g., palate expanders).
• Must not have current cleft palate, fluency disorder, or voice disorder.
• Must not demonstrate childhood apraxia of speech (CAS-only) features in BOTH articulatory and rate/prosody domains of the ProCAD.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

26 participants in 2 patient groups

CONCURRENT treatment order

Experimental group

Description:

* 5 speech lessons with a human speech-language clinician: 1 time per week for 5 weeks. * 15 speech lessons with an AI clinician (supervised by the caregiver), 3 times per week DURING the same 5 weeks as the human clinician sessions.

Treatment:

Behavioral: Speech-Language Pathologist-led Speech Motor Chaining

Behavioral: Artificial Intelligence-led Speech Motor Chaining (CHAINING-AI)

SEQUENTIAL treatment order

Experimental group

Description:

* 5 speech lessons with a human speech-language clinician: 1 time per week for 5 weeks. * 15 speech lessons with an AI clinician (supervised by the caregiver), 3 times per week for the 5 weeks AFTER the human clinician sessions end.

Treatment:

Behavioral: Speech-Language Pathologist-led Speech Motor Chaining

Behavioral: Artificial Intelligence-led Speech Motor Chaining (CHAINING-AI)